Clinical Trials and Translational Research Advisory Committee (CTAC) Subcommittees
Ad Hoc Translational Research Strategy Subcommittee
Mission Statement
The purpose of the ad hoc Translational Research Strategy Subcommittee (TRSS) is to provide broad advice to the National Cancer Institute (NCI) Clinical Trials and Translational Research Advisory Committee (CTAC), National Cancer Advisory Board (NCAB), NCI Board of Scientific Advisors (BSA) and NCI leadership on enhancing and broadening the overall translational research portfolio.
Specifically, the TRSS will survey scientific horizons broadly to:
- Help identify the most provocative and impactful translational research questions;
- Examine and identify the most important opportunities for application of new technologies to translational research;
- Identify translational research knowledge gaps.
This subcommittee will be compromised of current and previous CTAC, NCAB, and BSA members.
Roster
Co-chairs
Chi V. Dang, M.D., Ph.D.
Scientific Director
Ludwig Institute for Cancer Research, New York
Professor, The Wistar Institute
Philadelphia, Pennsylvania
Nancy E. Davidson, M.D.
Senior Vice President, Director and Full Member
Clinical Research Division
Fred Hutchinson Cancer Research Center
President & Executive Director
Seattle Cancer Care Alliance
Head, Division of Medical Oncology
Department of Medicine
University of Washington
Seattle, Washington
Members
Francis Ali-Osman, D.Sc.
Margaret Harris and David Silverman Distinguished Professor of Neuro-Oncology Research
Professor of Surgery
Professor of Pathology
Department of Surgery and Pathology
Duke University Medical Center
Durham, North Carolina
Walter J. Curran, Jr., M.D., F.A.C.R.
Executive Director
Winship Cancer Institute of Emory University
Atlanta, Georgia
David A. Mankoff, M.D., Ph.D.
Gerd Muehllehner Professor of Radiology
Vice-Chair for Research
Department of Radiology
Perelman School of Medicine
University of Pennsylvania
Philadelphia, Pennsylvania
Lynn M. Matrisian, Ph.D., M.B.A.
Chief Research Officer
Pancreatic Cancer Action Network
Washington, D.C.
Roman Perez-Soler, M.D.
Chairman
Department of Oncology
Montefiore Medical Center
Deputy Director
Albert Einstein Cancer Center
Director
Division of Medical Oncology
Albert Einstein College of Medicine
Bronx, New York
Kevin M. Shannon M.D.
American Cancer Society Research Professor
Auerback Distinguished Professor of Molecular Oncology
Professor, Department of Pediatrics
School of Medicine
University of California, San Francisco
San Francisco, California
David A. Tuveson, M.D., Ph.D.
Roy J. Zuckerberg Professor
Director of the Cancer Center
Cold Spring Harbor Laboratory
Cold Spring Harbor, New York
Kevin P. White, Ph.D.
President, Tempus Labs
James and Karen Frank Family Professor Department of Human Genetics
Professor, Department of Ecology and Evolution
Director, Institute for Genomics and Systems Biology
Knapp Center for Biomedical Discovery The University of Chicago
Chicago, Illinois
Max S. Wicha, M.D.
Deputy Director of the Taubman Institute Distinguished
Professor of Oncology
Professor, Internal Medicine
Division of Hematology and Oncology
University of Michigan
Ann Arbor, Michigan
Ex Officio Member
James H. Doroshow, M.D.
Deputy Director
Clinical and Translational Research
Director, Division of Cancer Treatment and Diagnosis
National Cancer Institute
National Institutes of Health
Bethesda, Maryland
Executive Secretary
Peter Ujhazy, M.D., Ph.D.
Deputy Associate Director
Translational Research Program
Division of Cancer Treatment and Diagnosis
National Cancer Institute
National Institutes of Health
Bethesda, Maryland